Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.4348308010088693e-42,125.48855421686747,12090.51186211136,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.964514571490688e-40,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,7.654745656028533e-27,42.54289071680376,2558.294258192268,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.3242709984929362e-24,0,0,48
3,Nonalcoholic fatty liver disease WP4396,3.4030384550191134e-18,12.59608644859813,506.63806319593016,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",3.9248376847887105e-16,0,0,43
4,Oxidative phosphorylation WP623,1.2515612401595143e-13,28.77574370709382,854.9047406033042,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5']",1.0826004727379798e-11,0,0,25
5,Mitochondrial complex I assembly model OXPHOS system WP4324,2.2658536883355043e-12,68.71444823663253,1842.4452778488856,"['NDUFA8', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",1.567970752328169e-10,0,0,20
6,Mitochondrial CIV Assembly WP4922,4.0291887899238016e-11,61.70261066969353,1476.844024277992,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",2.3234988688560587e-09,0,0,18
7,Mitochondrial complex III assembly WP4921,7.469646312228574e-06,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.00036921394629015525,0,0,8
8,mRNA Processing WP411,0.00021397462712796202,13.55331088664422,114.5207755491101,"['U2AF1L5', 'SF3B5', 'LSM7', 'SNRPD1', 'NCBP2', 'SNRPE', 'SRSF9', 'LSM2']",0.009254402623284358,0,0,8
9,Pyrimidine metabolism WP4022,0.0003882260002474166,5.095264937993235,40.017818044561096,"['NT5C', 'POLE4', 'POLD4', 'RRM2', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.014925132898400683,0,0,12
10,Cellular Proteostasis WP4918,0.0027520096339513863,inf,inf,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.09521953333471797,0,0,4
11,Proteasome Degradation WP183,0.006303075255394828,6.759238521836506,34.2471529765777,"['PSMD8', 'PSMB6', 'PSMD7', 'H2AFZ', 'PSMB10', 'PSMB9']",0.1982603671242373,0,0,6
12,Dual hijack model of Vif in HIV infection WP3300,0.012030915125919835,inf,inf,"['ELOB', 'ELOC', 'RUNX1']",0.34689138613068854,0,0,3
13,DNA Repair Pathways Full Network WP4946,0.015020919415933334,3.943385650224215,16.555561015666104,"['POLE4', 'POLD4', 'DCLRE1C', 'NEIL2', 'CENPX', 'APEX1', 'POLE3']",0.39978754753176415,0,0,7
14,Base Excision Repair WP4752,0.018785563784725803,5.626398210290827,22.363056976726245,"['POLE4', 'POLD4', 'NEIL2', 'APEX1', 'POLE3']",0.464271790679652,0,0,5
15,Modulators of TCR signaling and T cell activation WP5072,0.052533414100176805,2.626307922272048,7.737906402612933,"['ZAP70', 'FIBP', 'NDUFB10', 'TNFAIP3', 'RHOH', 'ELOB', 'RNF7']",0.9998923691042537,0,0,7
16,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.05255002181249104,inf,inf,"['ELOB', 'ELOC']",0.9998923691042537,0,0,2
17,Amyotrophic lateral sclerosis (ALS) WP2447,0.05288587872386808,4.4960893854748605,13.216789417220319,"['BAD', 'SLC1A2', 'BAX', 'NEFH']",0.9998923691042537,0,0,4
18,"GPCRs, Class B Secretin-like WP334",0.08280297109353282,5.054129464285714,12.591308942681023,"['ADGRE1', 'ADGRE2', 'GIPR']",0.9998923691042537,0,0,3
19,Nucleotide metabolism WP404,0.08280297109353282,5.054129464285714,12.591308942681023,"['RRM2', 'NME2', 'OAZ1']",0.9998923691042537,0,0,3
20,Osteoclast Signaling WP12,0.08280297109353282,5.054129464285714,12.591308942681023,"['AIMP2', 'ATP6V1G1', 'TNFRSF11B']",0.9998923691042537,0,0,3
21,Photodynamic therapy-induced unfolded protein response WP3613,0.08280297109353282,5.054129464285714,12.591308942681023,"['NARS', 'XBP1', 'DDIT3']",0.9998923691042537,0,0,3
22,Ferroptosis WP4313,0.08390766198952394,2.8104026845637584,6.964285622298502,"['MAP1LC3A', 'GPX4', 'FTH1', 'SAT2', 'FTL']",0.9998923691042537,0,0,5
23,Selenium Micronutrient Network WP15,0.0945817960512621,1.7696267696267696,4.173293560823934,"['SELENOM', 'PRDX5', 'GPX4', 'ALOX5', 'ALOX5AP', 'SELENOW', 'TXN', 'F2', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9998923691042537,0,0,11
24,Ciliary landscape WP4352,0.1138380130821393,1.6886261261261262,3.6693487376579856,"['PSMD8', 'PSMD7', 'EXOSC4', 'NDUFA5', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'DCAF11', 'LSM4']",0.9998923691042537,0,0,11
25,Non-small cell lung cancer WP4255,0.11766690697514126,2.4081176094598913,5.1531247761827,"['BAD', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.9998923691042537,0,0,5
26,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.13358829391515029,6.73355629877369,13.554599284692253,"['COX8A', 'COX5A']",0.9998923691042537,0,0,2
27,Biomarkers for pyrimidine metabolism disorders WP4584,0.13358829391515029,6.73355629877369,13.554599284692253,"['NT5C', 'RRM2']",0.9998923691042537,0,0,2
28,"COVID-19, thrombosis and anticoagulation WP4927",0.13358829391515029,6.73355629877369,13.554599284692253,"['F13A1', 'F2']",0.9998923691042537,0,0,2
29,Fatty acid transporters WP5061,0.13358829391515029,6.73355629877369,13.554599284692253,"['FABP6', 'FABP7']",0.9998923691042537,0,0,2
30,Iron metabolism in placenta WP2007,0.13358829391515029,6.73355629877369,13.554599284692253,"['HEPHL1', 'FTH1']",0.9998923691042537,0,0,2
31,Peroxiredoxin 2 induced ovarian failure WP4873,0.13358829391515029,6.73355629877369,13.554599284692253,"['STAR', 'BAX']",0.9998923691042537,0,0,2
32,Pyrimidine metabolism and related diseases WP4225,0.13358829391515029,6.73355629877369,13.554599284692253,"['NT5C', 'RRM2']",0.9998923691042537,0,0,2
33,RalA downstream regulated genes WP2290,0.13358829391515029,6.73355629877369,13.554599284692253,"['RAC3', 'HRAS']",0.9998923691042537,0,0,2
34,DNA Mismatch Repair WP531,0.1379846100737429,3.3683035714285716,6.671306249920104,"['POLE4', 'POLD4', 'POLE3']",0.9998923691042537,0,0,3
35,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.1379846100737429,3.3683035714285716,6.671306249920104,"['XBP1', 'MAP1LC3A', 'DDIT3']",0.9998923691042537,0,0,3
36,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.1379846100737429,3.3683035714285716,6.671306249920104,"['H3F3B', 'H2AFZ', 'HIST1H3E']",0.9998923691042537,0,0,3
37,Histone Modifications WP2369,0.1379846100737429,3.3683035714285716,6.671306249920104,"['SET', 'H3F3B', 'HIST1H3E']",0.9998923691042537,0,0,3
38,Nanomaterial induced apoptosis WP2507,0.1379846100737429,3.3683035714285716,6.671306249920104,"['ENDOG', 'BAX', 'CYCS']",0.9998923691042537,0,0,3
39,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1379846100737429,3.3683035714285716,6.671306249920104,"['ZAP70', 'HLA-DRB5', 'HLA-DRA']",0.9998923691042537,0,0,3
40,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.2002256005014103,1.871737509321402,3.0103351749187865,"['BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9998923691042537,0,0,5
41,Computational Model of Aerobic Glycolysis WP4629,0.20180867317888468,2.525390625,4.0417240320786245,"['TPI1', 'ALDOA', 'PFKM']",0.9998923691042537,0,0,3
42,Eukaryotic Transcription Initiation WP405,0.20180867317888468,2.525390625,4.0417240320786245,"['POLR2I', 'POLR2J', 'POLR2K']",0.9998923691042537,0,0,3
43,Macrophage markers WP4146,0.20180867317888468,2.525390625,4.0417240320786245,"['CD163', 'CD14', 'CD68']",0.9998923691042537,0,0,3
44,Nucleotide Excision Repair WP4753,0.20180867317888468,2.525390625,4.0417240320786245,"['POLE4', 'POLD4', 'POLE3']",0.9998923691042537,0,0,3
45,Acute viral myocarditis WP4298,0.21427230460651248,1.6847704367301233,2.5954016981059884,"['ENDOG', 'ITGB2', 'RAC3', 'CYCS', 'BAX', 'AIF1']",0.9998923691042537,0,0,6
46,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.22730889553610245,3.3656633221850614,4.986046491116896,"['H3F3B', 'HIST1H3E']",0.9998923691042537,0,0,2
47,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.22730889553610245,3.3656633221850614,4.986046491116896,"['BAD', 'BAX']",0.9998923691042537,0,0,2
48,Methionine De Novo and Salvage Pathway WP3580,0.22730889553610245,3.3656633221850614,4.986046491116896,"['AHCY', 'TXN']",0.9998923691042537,0,0,2
49,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.22730889553610245,3.3656633221850614,4.986046491116896,"['PTTG1', 'ANAPC11']",0.9998923691042537,0,0,2
50,Glycerolipids and Glycerophospholipids WP4722,0.22933649755918697,inf,inf,['CDIPT'],0.9998923691042537,0,0,1
51,Glycerophospholipid Biosynthetic Pathway WP2533,0.22933649755918697,inf,inf,['CDIPT'],0.9998923691042537,0,0,1
52,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.22933649755918697,inf,inf,['MAP1LC3A'],0.9998923691042537,0,0,1
53,Mitochondrial CII Assembly WP4920,0.22933649755918697,inf,inf,['SDHAF1'],0.9998923691042537,0,0,1
54,Nanoparticle triggered autophagic cell death WP2509,0.22933649755918697,inf,inf,['MAP1LC3A'],0.9998923691042537,0,0,1
55,Non-homologous end joining WP438,0.22933649755918697,inf,inf,['DCLRE1C'],0.9998923691042537,0,0,1
56,TP53 network WP1742,0.27070214032044526,2.0196428571428573,2.6391403835822462,"['SUMO1', 'GADD45A', 'BAX']",0.9998923691042537,0,0,3
57,IL-6 signaling pathway WP364,0.27070214032044526,2.0196428571428573,2.6391403835822462,"['HCK', 'BAD', 'AGT']",0.9998923691042537,0,0,3
58,IL1 and megakaryocytes in obesity WP2865,0.27070214032044526,2.0196428571428573,2.6391403835822462,"['TLR1', 'F2', 'S100A9']",0.9998923691042537,0,0,3
59,MET in type 1 papillary renal cell carcinoma WP4205,0.27070214032044526,2.0196428571428573,2.6391403835822462,"['BAD', 'RPL11', 'HRAS']",0.9998923691042537,0,0,3
60,16p11.2 proximal deletion syndrome WP4949,0.2881984486419116,1.6832402234636872,2.094129225015568,"['SPN', 'ALDOA', 'SEZ6L2', 'CDIPT']",0.9998923691042537,0,0,4
61,Pancreatic adenocarcinoma pathway WP4263,0.2881984486419116,1.6832402234636872,2.094129225015568,"['BAD', 'GADD45A', 'RAC3', 'BAX']",0.9998923691042537,0,0,4
62,BDNF-TrkB Signaling WP3676,0.3236461623569021,2.2430323299888517,2.5303747562005987,"['TRPC6', 'HRAS']",0.9998923691042537,0,0,2
63,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.3236461623569021,2.2430323299888517,2.5303747562005987,"['HSD11B2', 'STAR']",0.9998923691042537,0,0,2
64,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3236461623569021,2.2430323299888517,2.5303747562005987,"['MAP1LC3A', 'FTL']",0.9998923691042537,0,0,2
65,Copper homeostasis WP3286,0.34152106289885864,1.6824776785714286,1.8075630366615727,"['SCO2', 'COX17', 'ATOX1']",0.9998923691042537,0,0,3
66,TNF-alpha signaling pathway WP231,0.3460730670444302,1.3464725643896978,1.428749241419405,"['BAD', 'TNFAIP3', 'BAX', 'CYBA', 'TXN', 'HRAS']",0.9998923691042537,0,0,6
67,Melanoma WP4685,0.3466326069186164,1.4957169459962756,1.5846968922656024,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.9998923691042537,0,0,4
68,Sleep regulation WP3591,0.4051953911242892,1.3456983240223463,1.2156848660009254,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9998923691042537,0,0,4
69,Endometrial cancer WP4155,0.4051953911242892,1.3456983240223463,1.2156848660009254,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.9998923691042537,0,0,4
70,Genotoxicity pathway WP4286,0.4051953911242892,1.3456983240223463,1.2156848660009254,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9998923691042537,0,0,4
71,The alternative pathway of fetal androgen synthesis WP4524,0.406122830378555,3.363028953229399,3.0304241362113458,['STAR'],0.9998923691042537,0,0,1
72,Fatty acid beta-oxidation WP143,0.406122830378555,3.363028953229399,3.0304241362113458,['TPI1'],0.9998923691042537,0,0,1
73,Immune response to tuberculosis WP4197,0.406122830378555,3.363028953229399,3.0304241362113458,['IFIT3'],0.9998923691042537,0,0,1
74,Metabolism of alpha-linolenic acid WP4586,0.406122830378555,3.363028953229399,3.0304241362113458,['ALOX5'],0.9998923691042537,0,0,1
75,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.406122830378555,3.363028953229399,3.0304241362113458,['AHCY'],0.9998923691042537,0,0,1
76,Nanoparticle triggered regulated necrosis WP2513,0.406122830378555,3.363028953229399,3.0304241362113458,['FTL'],0.9998923691042537,0,0,1
77,Nanoparticle-mediated activation of receptor signaling WP2643,0.406122830378555,3.363028953229399,3.0304241362113458,['HRAS'],0.9998923691042537,0,0,1
78,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.406122830378555,3.363028953229399,3.0304241362113458,['BAX'],0.9998923691042537,0,0,1
79,Serotonin and anxiety WP3947,0.41647690403780546,1.6817168338907469,1.4730565924319945,"['POMC', 'CRH']",0.9998923691042537,0,0,2
80,Monoamine Transport WP727,0.41647690403780546,1.6817168338907469,1.4730565924319945,"['TNFRSF11B', 'AGT']",0.9998923691042537,0,0,2
81,p38 MAPK Signaling Pathway WP400,0.41647690403780546,1.6817168338907469,1.4730565924319945,"['DDIT3', 'HRAS']",0.9998923691042537,0,0,2
82,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.41647690403780546,1.6817168338907469,1.4730565924319945,"['BAD', 'HRAS']",0.9998923691042537,0,0,2
83,IL-18 signaling pathway WP4754,0.4471316977767755,1.0766930917327293,0.8666325325975072,"['NRN1', 'IMP3', 'BAD', 'COX17', 'TNFAIP3', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'GATA1', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'PTPN7', 'ITM2C']",0.9998923691042537,0,0,16
84,Regulation of Actin Cytoskeleton WP51,0.4696138377105543,1.1210762331838564,0.8473593541331093,"['FGF17', 'GSN', 'TMSB4X', 'BRK1', 'RAC3', 'CD14', 'F2']",0.9998923691042537,0,0,7
85,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.4793487162325212,1.2610212053571428,0.92726286119017,"['TYROBP', 'ITGB2', 'CD14']",0.9998923691042537,0,0,3
86,Microglia Pathogen Phagocytosis Pathway WP3937,0.4830275750682139,1.1209406494960805,0.815687813277032,"['HCK', 'TYROBP', 'NCF4', 'ITGB2', 'RAC3', 'CYBA']",0.9998923691042537,0,0,6
87,7q11.23 copy number variation syndrome WP4932,0.4987708856110154,1.1208053691275168,0.7796416695911758,"['ATP5MC2', 'FZD9', 'ATP5MC3', 'ATP5F1E', 'ATP5MC1']",0.9998923691042537,0,0,5
88,Glycolysis and Gluconeogenesis WP534,0.4987708856110154,1.1208053691275168,0.7796416695911758,"['LDHC', 'TPI1', 'SLC2A5', 'ALDOA', 'PFKM']",0.9998923691042537,0,0,5
89,Integrin-mediated Cell Adhesion WP185,0.4987708856110154,1.1208053691275168,0.7796416695911758,"['SHC3', 'ITGB2', 'ITGA8', 'RAC3', 'HRAS']",0.9998923691042537,0,0,5
90,Transcriptional cascade regulating adipogenesis WP4211,0.5023441502374419,1.344927536231884,0.9259420402156381,"['EGR2', 'DDIT3']",0.9998923691042537,0,0,2
91,Unfolded protein response WP4925,0.5023441502374419,1.344927536231884,0.9259420402156381,"['XBP1', 'DDIT3']",0.9998923691042537,0,0,2
92,Cori Cycle WP1946,0.5023441502374419,1.344927536231884,0.9259420402156381,"['TPI1', 'ALDOA']",0.9998923691042537,0,0,2
93,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5023441502374419,1.344927536231884,0.9259420402156381,"['BANF1', 'HRAS']",0.9998923691042537,0,0,2
94,Fluoropyrimidine Activity WP1601,0.5023441502374419,1.344927536231884,0.9259420402156381,"['RRM2', 'UPP2']",0.9998923691042537,0,0,2
95,Genes related to primary cilium development (based on CRISPR) WP4536,0.5023441502374419,1.344927536231884,0.9259420402156381,"['TMEM17', 'DYNLL1']",0.9998923691042537,0,0,2
96,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5023441502374419,1.344927536231884,0.9259420402156381,"['STAR', 'HRAS']",0.9998923691042537,0,0,2
97,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5180107728394201,1.1206703910614526,0.7371313046608556,"['SHC3', 'BAD', 'BAX', 'HRAS']",0.9998923691042537,0,0,4
98,Complement system WP2806,0.5192777359103317,1.0433165439752035,0.683702444080876,"['FKBP2', 'FCGR3A', 'RPS19', 'ITGB2', 'F11', 'F13A1', 'CD59', 'VSIG4', 'TXN']",0.9998923691042537,0,0,9
99,Serotonin and anxiety-related events WP3944,0.5423899879731497,1.680957683741648,1.0283594843306965,['CRH'],0.9998923691042537,0,0,1
100,Alanine and aspartate metabolism WP106,0.5423899879731497,1.680957683741648,1.0283594843306965,['ASPA'],0.9998923691042537,0,0,1
101,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.5423899879731497,1.680957683741648,1.0283594843306965,['IDH3B'],0.9998923691042537,0,0,1
102,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5423899879731497,1.680957683741648,1.0283594843306965,['SST'],0.9998923691042537,0,0,1
103,Trans-sulfuration and one-carbon metabolism WP2525,0.5423899879731497,1.680957683741648,1.0283594843306965,['AHCY'],0.9998923691042537,0,0,1
104,Trans-sulfuration pathway WP2333,0.5423899879731497,1.680957683741648,1.0283594843306965,['AHCY'],0.9998923691042537,0,0,1
105,Cysteine and methionine catabolism WP4504,0.5423899879731497,1.680957683741648,1.0283594843306965,['AHCY'],0.9998923691042537,0,0,1
106,Ganglio Sphingolipid Metabolism WP1423,0.5423899879731497,1.680957683741648,1.0283594843306965,['B4GALNT1'],0.9998923691042537,0,0,1
107,Glycosylation and related congenital defects WP4521,0.5423899879731497,1.680957683741648,1.0283594843306965,['DPM3'],0.9998923691042537,0,0,1
108,HIF1A and PPARG regulation of glycolysis WP2456,0.5423899879731497,1.680957683741648,1.0283594843306965,['TPI1'],0.9998923691042537,0,0,1
109,Homologous recombination WP186,0.5423899879731497,1.680957683741648,1.0283594843306965,['POLD4'],0.9998923691042537,0,0,1
110,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5423899879731497,1.680957683741648,1.0283594843306965,['HRAS'],0.9998923691042537,0,0,1
111,Interleukin-11 Signaling Pathway WP2332,0.5423899879731497,1.680957683741648,1.0283594843306965,['HRAS'],0.9998923691042537,0,0,1
112,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5423899879731497,1.680957683741648,1.0283594843306965,['B4GALNT1'],0.9998923691042537,0,0,1
113,MTHFR deficiency WP4288,0.5423899879731497,1.680957683741648,1.0283594843306965,['CYCS'],0.9998923691042537,0,0,1
114,Osteoblast Signaling WP322,0.5423899879731497,1.680957683741648,1.0283594843306965,['TNFRSF11B'],0.9998923691042537,0,0,1
115,Overview of nanoparticle effects WP3287,0.5423899879731497,1.680957683741648,1.0283594843306965,['BAX'],0.9998923691042537,0,0,1
116,Purine metabolism and related disorders WP4224,0.5423899879731497,1.680957683741648,1.0283594843306965,['APRT'],0.9998923691042537,0,0,1
117,Purine metabolism WP4792,0.5423899879731497,1.680957683741648,1.0283594843306965,['APRT'],0.9998923691042537,0,0,1
118,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.5423899879731497,1.680957683741648,1.0283594843306965,['AGT'],0.9998923691042537,0,0,1
119,p53 transcriptional gene network WP4963,0.543065434666956,1.1205357142857142,0.6841155829442177,"['GADD45A', 'BAX', 'TNFRSF10D']",0.9998923691042537,0,0,3
120,Senescence and Autophagy in Cancer WP615,0.5693499606122069,1.008174692049272,0.567864465858788,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3A', 'GSN', 'HRAS', 'GABARAP']",0.9998923691042537,0,0,6
121,Ras signaling WP4223,0.5702941212194048,0.9956353660057363,0.5591518573381862,"['ZAP70', 'GNG10', 'GNG3', 'SHC3', 'BAD', 'RAC3', 'RASAL3', 'HRAS']",0.9998923691042537,0,0,8
122,Pathways in clear cell renal cell carcinoma WP4018,0.5705253662981262,1.0341211860764934,0.5803463767463453,"['LDHC', 'TPI1', 'ALDOA', 'PFKM']",0.9998923691042537,0,0,4
123,CAMKK2  Pathway WP4874,0.5795580997437596,1.120401337792642,0.6111670118621443,"['FIS1', 'MAP1LC3A']",0.9998923691042537,0,0,2
124,Cancer immunotherapy by PD-1 blockade WP4585,0.5795580997437596,1.120401337792642,0.6111670118621443,"['ZAP70', 'BATF']",0.9998923691042537,0,0,2
125,Type 2 papillary renal cell carcinoma WP4241,0.5795580997437596,1.120401337792642,0.6111670118621443,"['ELOB', 'ELOC']",0.9998923691042537,0,0,2
126,DNA Replication WP466,0.5795580997437596,1.120401337792642,0.6111670118621443,"['POLD4', 'UBA52']",0.9998923691042537,0,0,2
127,Eicosanoid Synthesis WP167,0.5795580997437596,1.120401337792642,0.6111670118621443,"['ALOX5', 'ALOX5AP']",0.9998923691042537,0,0,2
128,Integrated Cancer Pathway WP1971,0.5795580997437596,1.120401337792642,0.6111670118621443,"['BAD', 'BAX']",0.9998923691042537,0,0,2
129,Regulation of Microtubule Cytoskeleton WP2038,0.5795580997437596,1.120401337792642,0.6111670118621443,"['PARD6A', 'F2RL2']",0.9998923691042537,0,0,2
130,Insulin Signaling WP481,0.5919190798231,0.9882879326227135,0.5182437064609517,"['XBP1', 'SHC3', 'RHOJ', 'HRAS', 'PFKM']",0.9998923691042537,0,0,5
131,IL-3 signaling pathway WP286,0.6019952407293016,1.0081473214285714,0.5116405518561522,"['HCK', 'BAD', 'HRAS']",0.9998923691042537,0,0,3
132,Oxidative Damage WP3941,0.6019952407293016,1.0081473214285714,0.5116405518561522,"['BAD', 'GADD45A', 'CYCS']",0.9998923691042537,0,0,3
133,Androgen receptor signaling pathway WP138,0.6196704554161353,0.9599361532322426,0.45939421215725834,"['SUMO1', 'BAG1', 'DSTN', 'STUB1']",0.9998923691042537,0,0,4
134,15q13.3 copy number variation syndrome WP4942,0.6474169178778866,1.1202672605790647,0.4870527779884752,['TRPM1'],0.9998923691042537,0,0,1
135,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6474169178778866,1.1202672605790647,0.4870527779884752,['HRAS'],0.9998923691042537,0,0,1
136,ACE Inhibitor Pathway WP554,0.6474169178778866,1.1202672605790647,0.4870527779884752,['AGT'],0.9998923691042537,0,0,1
137,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.6474169178778866,1.1202672605790647,0.4870527779884752,['DLL3'],0.9998923691042537,0,0,1
138,Sphingolipid pathway WP1422,0.6474169178778866,1.1202672605790647,0.4870527779884752,['ACER1'],0.9998923691042537,0,0,1
139,Transcription co-factors SKI and SKIL protein partners WP4533,0.6474169178778866,1.1202672605790647,0.4870527779884752,['MERTK'],0.9998923691042537,0,0,1
140,Type II diabetes mellitus WP1584,0.6474169178778866,1.1202672605790647,0.4870527779884752,['SURF1'],0.9998923691042537,0,0,1
141,Energy Metabolism WP1541,0.6474169178778866,1.1202672605790647,0.4870527779884752,['UCP3'],0.9998923691042537,0,0,1
142,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6474169178778866,1.1202672605790647,0.4870527779884752,['MAP1LC3A'],0.9998923691042537,0,0,1
143,Gastric acid production WP2596,0.6474169178778866,1.1202672605790647,0.4870527779884752,['CCK'],0.9998923691042537,0,0,1
144,Genes targeted by miRNAs in adipocytes WP1992,0.6474169178778866,1.1202672605790647,0.4870527779884752,['TMSB4X'],0.9998923691042537,0,0,1
145,Glutathione metabolism WP100,0.6474169178778866,1.1202672605790647,0.4870527779884752,['GPX4'],0.9998923691042537,0,0,1
146,Intraflagellar transport proteins binding to dynein WP4532,0.6474169178778866,1.1202672605790647,0.4870527779884752,['DYNLL1'],0.9998923691042537,0,0,1
147,LTF danger signal response pathway WP4478,0.6474169178778866,1.1202672605790647,0.4870527779884752,['CD14'],0.9998923691042537,0,0,1
148,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6474169178778866,1.1202672605790647,0.4870527779884752,['BAX'],0.9998923691042537,0,0,1
149,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6474169178778866,1.1202672605790647,0.4870527779884752,['BAX'],0.9998923691042537,0,0,1
150,NOTCH1 regulation of endothelial cell calcification WP3413,0.6474169178778866,1.1202672605790647,0.4870527779884752,['DLL3'],0.9998923691042537,0,0,1
151,NRF2-ARE regulation WP4357,0.6474169178778866,1.1202672605790647,0.4870527779884752,['AIMP2'],0.9998923691042537,0,0,1
152,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.6474169178778866,1.1202672605790647,0.4870527779884752,['EIF1'],0.9998923691042537,0,0,1
153,PDGFR-beta pathway WP3972,0.6474169178778866,1.1202672605790647,0.4870527779884752,['HRAS'],0.9998923691042537,0,0,1
154,Phytochemical activity on NRF2 transcriptional activation WP3,0.6474169178778866,1.1202672605790647,0.4870527779884752,['AIMP2'],0.9998923691042537,0,0,1
155,Vitamin D-sensitive calcium signaling in depression WP4698,0.6475686224985744,0.9600254817646122,0.4171603625221543,"['GPX4', 'PVALB']",0.9998923691042537,0,0,2
156,DNA IR-double strand breaks and cellular response via ATM WP3959,0.6475686224985744,0.9600254817646122,0.4171603625221543,"['DCLRE1C', 'BAX']",0.9998923691042537,0,0,2
157,Kit receptor signaling pathway WP304,0.6475686224985744,0.9600254817646122,0.4171603625221543,"['BAD', 'HRAS']",0.9998923691042537,0,0,2
158,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6475686224985744,0.9600254817646122,0.4171603625221543,"['BAD', 'CYCS']",0.9998923691042537,0,0,2
159,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6556678809048008,0.9161931818181818,0.3867259641906036,"['APEX1', 'HRAS', 'MYL12B']",0.9998923691042537,0,0,3
160,Corticotropin-releasing hormone signaling pathway WP2355,0.6651176914395132,0.8956424581005586,0.36523517937500766,"['POMC', 'STAR', 'CRH', 'FOSB']",0.9998923691042537,0,0,4
161,NRF2 pathway WP2884,0.6709473898210598,0.8951739618406285,0.35723219489471836,"['SERPINA1', 'FTH1', 'SLC39A11', 'TXN', 'SLC2A5', 'SLC5A3', 'FTL', 'CBR3']",0.9998923691042537,0,0,8
162,Integrated breast cancer pathway WP1984,0.6746264918340391,0.883668903803132,0.34780862246897903,"['GADD45A', 'BAD', 'BAX', 'PHB', 'FAU']",0.9998923691042537,0,0,5
163,ErbB signaling pathway WP673,0.7039219479418182,0.8395647321428571,0.2947609333982993,"['SHC3', 'BAD', 'HRAS']",0.9998923691042537,0,0,3
164,G Protein Signaling Pathways WP35,0.7039219479418182,0.8395647321428571,0.2947609333982993,"['GNG10', 'GNG3', 'HRAS']",0.9998923691042537,0,0,3
165,Leptin signaling pathway WP2034,0.7039219479418182,0.8395647321428571,0.2947609333982993,"['BAD', 'BAX', 'HRAS']",0.9998923691042537,0,0,3
166,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7039219479418182,0.8395647321428571,0.2947609333982993,"['PSMD8', 'PSMD7', 'STUB1']",0.9998923691042537,0,0,3
167,Blood Clotting Cascade WP272,0.7065322199162146,0.8397435897435898,0.2917155637986091,"['F11', 'F2']",0.9998923691042537,0,0,2
168,Development of ureteric collection system WP5053,0.7065322199162146,0.8397435897435898,0.2917155637986091,"['ITGA8', 'PAX2']",0.9998923691042537,0,0,2
169,Notch Signaling WP268,0.7065322199162146,0.8397435897435898,0.2917155637986091,"['DTX3L', 'DLL3']",0.9998923691042537,0,0,2
170,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7065322199162146,0.8397435897435898,0.2917155637986091,"['IGFBP2', 'BAX']",0.9998923691042537,0,0,2
171,PPAR signaling pathway WP3942,0.7065322199162146,0.8397435897435898,0.2917155637986091,"['FABP6', 'FABP7']",0.9998923691042537,0,0,2
172,DNA damage response (only ATM dependent) WP710,0.7067043517504994,0.8393854748603352,0.2913866856812977,"['BAD', 'RAC3', 'BAX', 'HRAS']",0.9998923691042537,0,0,4
173,Chemokine signaling pathway WP3929,0.7172269589163609,0.8390257558790594,0.27886107437525953,"['CCR1', 'HCK', 'GNG10', 'GNG3', 'SHC3', 'HRAS']",0.9998923691042537,0,0,6
174,Apoptosis Modulation by HSP70 WP384,0.7283595087088999,0.8399220489977728,0.2662221311195297,['CYCS'],0.9998923691042537,0,0,1
175,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7283595087088999,0.8399220489977728,0.2662221311195297,['HRAS'],0.9998923691042537,0,0,1
176,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7283595087088999,0.8399220489977728,0.2662221311195297,['CCK'],0.9998923691042537,0,0,1
177,Wnt signaling in kidney disease WP4150,0.7283595087088999,0.8399220489977728,0.2662221311195297,['FZD9'],0.9998923691042537,0,0,1
178,COVID-19 adverse outcome pathway WP4891,0.7283595087088999,0.8399220489977728,0.2662221311195297,['AGT'],0.9998923691042537,0,0,1
179,Galanin receptor pathway WP4970,0.7283595087088999,0.8399220489977728,0.2662221311195297,['POMC'],0.9998923691042537,0,0,1
180,ID signaling pathway WP53,0.7283595087088999,0.8399220489977728,0.2662221311195297,['PAX2'],0.9998923691042537,0,0,1
181,IL-7 signaling pathway WP205,0.7283595087088999,0.8399220489977728,0.2662221311195297,['BAD'],0.9998923691042537,0,0,1
182,MAPK Cascade WP422,0.7283595087088999,0.8399220489977728,0.2662221311195297,['HRAS'],0.9998923691042537,0,0,1
183,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7283595087088999,0.8399220489977728,0.2662221311195297,['SCO2'],0.9998923691042537,0,0,1
184,Prion disease pathway WP3995,0.7283595087088999,0.8399220489977728,0.2662221311195297,['BATF'],0.9998923691042537,0,0,1
185,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7468244754409775,0.7747252747252747,0.22616174872243222,"['TMSB4X', 'FZD9', 'NEFH']",0.9998923691042537,0,0,3
186,3q29 copy number variation syndrome WP4906,0.7570173773629765,0.7461910070605723,0.20771649685899354,"['NCBP2', 'DYNLL1']",0.9998923691042537,0,0,2
187,Translation Factors WP107,0.7570173773629765,0.7461910070605723,0.20771649685899354,"['EEF1B2', 'EIF1']",0.9998923691042537,0,0,2
188,Nephrotic syndrome WP4758,0.7570173773629765,0.7461910070605723,0.20771649685899354,"['TRPC6', 'PAX2']",0.9998923691042537,0,0,2
189,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7570173773629765,0.7461910070605723,0.20771649685899354,"['STAR', 'AGT']",0.9998923691042537,0,0,2
190,Apoptosis Modulation and Signaling WP1772,0.7780146362161365,0.7823991031390135,0.1963899537842236,"['ENDOG', 'BAD', 'CYCS', 'BAX', 'TNFRSF11B', 'TNFRSF10A', 'TNFRSF10D']",0.9998923691042537,0,0,7
191,TGF-beta Signaling Pathway WP366,0.778287116867912,0.7456238361266294,0.18689790528471797,"['PARD6A', 'CITED1', 'SUMO1', 'FOSB']",0.9998923691042537,0,0,4
192,Proximal tubule transport WP4917,0.778287116867912,0.7456238361266294,0.18689790528471797,"['ATP6V1G1', 'SLC7A9', 'ATP6V1E1', 'ATP6V1F']",0.9998923691042537,0,0,4
193,DNA damage response WP707,0.784602802898624,0.7191485969387755,0.17444939305807036,"['GADD45A', 'CYCS', 'BAX']",0.9998923691042537,0,0,3
194,Folate Metabolism WP176,0.784602802898624,0.7191485969387755,0.17444939305807036,"['AHCY', 'GPX4', 'F2']",0.9998923691042537,0,0,3
195,Male infertility WP4673,0.784602802898624,0.7191485969387755,0.17444939305807036,"['EPSTI1', 'HLA-DRA', 'PEX10']",0.9998923691042537,0,0,3
196,miRNA regulation of DNA damage response WP1530,0.784602802898624,0.7191485969387755,0.17444939305807036,"['GADD45A', 'CYCS', 'BAX']",0.9998923691042537,0,0,3
197,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.784602802898624,0.7191485969387755,0.17444939305807036,"['BAD', 'BAX', 'HRAS']",0.9998923691042537,0,0,3
198,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7907359323990228,0.6717149220489977,0.1577127574119378,['CCR1'],0.9998923691042537,0,0,1
199,Type II interferon signaling (IFNG) WP619,0.7907359323990228,0.6717149220489977,0.1577127574119378,['PSMB9'],0.9998923691042537,0,0,1
200,Zinc homeostasis WP3529,0.7907359323990228,0.6717149220489977,0.1577127574119378,['SLC39A11'],0.9998923691042537,0,0,1
201,ERK Pathway in Huntington's Disease WP3853,0.7907359323990228,0.6717149220489977,0.1577127574119378,['HRAS'],0.9998923691042537,0,0,1
202,Ethanol effects on histone modifications WP3996,0.7907359323990228,0.6717149220489977,0.1577127574119378,['AHCY'],0.9998923691042537,0,0,1
203,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7907359323990228,0.6717149220489977,0.1577127574119378,['HRAS'],0.9998923691042537,0,0,1
204,Farnesoid X receptor pathway WP2879,0.7907359323990228,0.6717149220489977,0.1577127574119378,['SLCO2B1'],0.9998923691042537,0,0,1
205,Gastric Cancer Network 2 WP2363,0.7907359323990228,0.6717149220489977,0.1577127574119378,['S100A6'],0.9998923691042537,0,0,1
206,GDNF/RET signaling axis WP4830,0.7907359323990228,0.6717149220489977,0.1577127574119378,['PAX2'],0.9998923691042537,0,0,1
207,IL17 signaling pathway WP2112,0.7907359323990228,0.6717149220489977,0.1577127574119378,['IL17RB'],0.9998923691042537,0,0,1
208,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7907359323990228,0.6717149220489977,0.1577127574119378,['SUPT4H1'],0.9998923691042537,0,0,1
209,Interferon type I signaling pathways WP585,0.7907359323990228,0.6717149220489977,0.1577127574119378,['ZAP70'],0.9998923691042537,0,0,1
210,miRNA regulation of prostate cancer signaling pathways WP3981,0.7907359323990228,0.6717149220489977,0.1577127574119378,['BAD'],0.9998923691042537,0,0,1
211,One-carbon metabolism and related pathways WP3940,0.7907359323990228,0.6717149220489977,0.1577127574119378,['GPX4'],0.9998923691042537,0,0,1
212,One-carbon metabolism WP241,0.7907359323990228,0.6717149220489977,0.1577127574119378,['AHCY'],0.9998923691042537,0,0,1
213,Parkinson's disease pathway WP2371,0.7907359323990228,0.6717149220489977,0.1577127574119378,['CYCS'],0.9998923691042537,0,0,1
214,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7907359323990228,0.6717149220489977,0.1577127574119378,['HRAS'],0.9998923691042537,0,0,1
215,SARS-CoV-2 mitochondrial interactions WP5038,0.7907359323990228,0.6717149220489977,0.1577127574119378,['PHB'],0.9998923691042537,0,0,1
216,Aryl Hydrocarbon Receptor Netpath WP2586,0.7998076986160073,0.6713489409141583,0.14996858290842463,"['AIP', 'HRAS']",0.9998923691042537,0,0,2
217,Aryl Hydrocarbon Receptor Pathway WP2873,0.7998076986160073,0.6713489409141583,0.14996858290842463,"['AIP', 'BAX']",0.9998923691042537,0,0,2
218,Synaptic Vesicle Pathway WP2267,0.7998076986160073,0.6713489409141583,0.14996858290842463,"['SLC32A1', 'SLC17A6']",0.9998923691042537,0,0,2
219,Cytosolic DNA-sensing pathway WP4655,0.7998076986160073,0.6713489409141583,0.14996858290842463,"['POLR2K', 'POLR2L']",0.9998923691042537,0,0,2
220,Genes controlling nephrogenesis WP4823,0.7998076986160073,0.6713489409141583,0.14996858290842463,"['ITGA8', 'PAX2']",0.9998923691042537,0,0,2
221,Pathways affected in adenoid cystic carcinoma WP3651,0.7998076986160073,0.6713489409141583,0.14996858290842463,"['UHRF1', 'HRAS']",0.9998923691042537,0,0,2
222,Breast cancer pathway WP4262,0.8021910791879397,0.7569072761463909,0.16682875660892338,"['FGF17', 'SHC3', 'GADD45A', 'FZD9', 'BAX', 'HRAS', 'DLL3']",0.9998923691042537,0,0,7
223,Adipogenesis WP236,0.8023193539790366,0.7450541246733856,0.16409709315929147,"['GDF10', 'EGR2', 'GADD45A', 'DDIT3', 'MIF', 'AGT']",0.9998923691042537,0,0,6
224,MAPK Signaling Pathway WP382,0.803122067991878,0.7660092993426326,0.16794643709494236,"['DUSP4', 'FGF17', 'GADD45A', 'DDIT3', 'RAC3', 'CD14', 'PTPN7', 'HRAS']",0.9998923691042537,0,0,8
225,Ebola Virus Pathway on Host WP4217,0.8040861682659003,0.7290146872872288,0.1589608076975566,"['HLA-DRB5', 'GSN', 'HLA-DRA', 'HLA-DOA', 'MERTK']",0.9998923691042537,0,0,5
226,Hepatitis B infection WP4666,0.8040861682659003,0.7290146872872288,0.1589608076975566,"['EGR2', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9998923691042537,0,0,5
227,Small cell lung cancer WP4658,0.8175892181177923,0.6709821428571429,0.13513261429484996,"['GADD45A', 'CYCS', 'BAX']",0.9998923691042537,0,0,3
228,Alzheimer's disease WP2059,0.8175892181177923,0.6709821428571429,0.13513261429484996,"['ATP5MD', 'BAD', 'CYCS']",0.9998923691042537,0,0,3
229,Hematopoietic Stem Cell Differentiation WP2849,0.8352912348600464,0.6706145251396648,0.12069373561278496,"['RHOH', 'FOSB', 'GATA1', 'RUNX1']",0.9998923691042537,0,0,4
230,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8357735317374297,0.6101145231580014,0.10945307974412023,"['SHC3', 'HRAS']",0.9998923691042537,0,0,2
231,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8357735317374297,0.6101145231580014,0.10945307974412023,"['NDUFA13', 'ACAP1']",0.9998923691042537,0,0,2
232,Pathogenic Escherichia coli infection WP2272,0.8357735317374297,0.6101145231580014,0.10945307974412023,"['ARPC5L', 'CD14']",0.9998923691042537,0,0,2
233,Prolactin Signaling Pathway WP2037,0.8357735317374297,0.6101145231580014,0.10945307974412023,"['ZAP70', 'HRAS']",0.9998923691042537,0,0,2
234,7-oxo-C and 7beta-HC pathways WP5064,0.8388011326511998,0.5595768374164811,0.0983633283853702,['HSD11B2'],0.9998923691042537,0,0,1
235,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8388011326511998,0.5595768374164811,0.0983633283853702,['HRAS'],0.9998923691042537,0,0,1
236,ATM Signaling Network in Development and Disease  WP3878,0.8388011326511998,0.5595768374164811,0.0983633283853702,['DCLRE1C'],0.9998923691042537,0,0,1
237,Cells and molecules involved in local acute inflammatory response  WP4493,0.8388011326511998,0.5595768374164811,0.0983633283853702,['ITGB2'],0.9998923691042537,0,0,1
238,Cytokines and Inflammatory Response WP530,0.8388011326511998,0.5595768374164811,0.0983633283853702,['HLA-DRA'],0.9998923691042537,0,0,1
239,Endothelin Pathways WP2197,0.8388011326511998,0.5595768374164811,0.0983633283853702,['RIIAD1'],0.9998923691042537,0,0,1
240,GABA receptor Signaling WP4159,0.8388011326511998,0.5595768374164811,0.0983633283853702,['SLC32A1'],0.9998923691042537,0,0,1
241,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8388011326511998,0.5595768374164811,0.0983633283853702,['DDIT3'],0.9998923691042537,0,0,1
242,Nephrogenesis WP5052,0.8388011326511998,0.5595768374164811,0.0983633283853702,['PAX2'],0.9998923691042537,0,0,1
243,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8388011326511998,0.5595768374164811,0.0983633283853702,['PIN1'],0.9998923691042537,0,0,1
244,PDGF Pathway WP2526,0.8388011326511998,0.5595768374164811,0.0983633283853702,['HRAS'],0.9998923691042537,0,0,1
245,Physiological and pathological hypertrophy of the heart WP1528,0.8388011326511998,0.5595768374164811,0.0983633283853702,['AGT'],0.9998923691042537,0,0,1
246,EGF/EGFR signaling pathway WP437,0.858863837569171,0.6384676775738228,0.09713958964878812,"['NDUFA13', 'FOSB', 'NEDD8', 'HRAS']",0.9998923691042537,0,0,4
247,VEGFA-VEGFR2 Signaling Pathway WP3888,0.8603670209413635,0.7859198286823261,0.11819936535648526,"['SET', 'SDF2L1', 'SSR4', 'ARPC5L', 'SARS', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RHOJ', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'ATP6V1E1', 'ALDOA', 'TMSB10', 'HRAS']",0.9998923691042537,0,0,20
248,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8657910716202416,0.5590858416945373,0.08057078666962719,"['BEX3', 'RNF7']",0.9998923691042537,0,0,2
249,Prostaglandin Synthesis and Regulation WP98,0.8657910716202416,0.5590858416945373,0.08057078666962719,"['HSD11B2', 'S100A6']",0.9998923691042537,0,0,2
250,ESC Pluripotency Pathways WP3931,0.870790440880847,0.5916491596638656,0.08185698469373799,"['FGF17', 'FZD9', 'HRAS']",0.9998923691042537,0,0,3
251,Alpha 6 Beta 4 signaling pathway WP244,0.8758357559547283,0.479478205536112,0.06356763764954747,['HRAS'],0.9998923691042537,0,0,1
252,Statin inhibition of cholesterol production WP430,0.8758357559547283,0.479478205536112,0.06356763764954747,['APOC1'],0.9998923691042537,0,0,1
253,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8758357559547283,0.479478205536112,0.06356763764954747,['ZAP70'],0.9998923691042537,0,0,1
254,Tumor suppressor activity of SMARCB1 WP4204,0.8758357559547283,0.479478205536112,0.06356763764954747,['H3F3B'],0.9998923691042537,0,0,1
255,IL-2 signaling pathway WP49,0.8758357559547283,0.479478205536112,0.06356763764954747,['HRAS'],0.9998923691042537,0,0,1
256,Joubert Syndrome WP4656,0.8758357559547283,0.479478205536112,0.06356763764954747,['TMEM17'],0.9998923691042537,0,0,1
257,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8758357559547283,0.479478205536112,0.06356763764954747,['HLA-DRA'],0.9998923691042537,0,0,1
258,RAS and bradykinin pathways in COVID-19 WP4969,0.8758357559547283,0.479478205536112,0.06356763764954747,['AGT'],0.9998923691042537,0,0,1
259,Circadian rhythm related genes WP3594,0.8791143273317089,0.6695067264573991,0.08625946391240569,"['AHCY', 'STAR', 'CRH', 'AVP', 'RPS27A', 'UBA52', 'HCRTR1']",0.9998923691042537,0,0,7
260,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8794957016574577,0.6092432706957847,0.07823085822617855,"['EGR2', 'SHC3', 'BAD', 'HRAS']",0.9998923691042537,0,0,4
261,Ciliopathies WP4803,0.8794957016574577,0.6092432706957847,0.07823085822617855,"['TMEM17', 'DNAAF3', 'CCNQ', 'CCDC28B']",0.9998923691042537,0,0,4
262,TYROBP causal network in microglia WP3945,0.8889954219538154,0.6201839423315934,0.07297282298872912,"['TYROBP', 'ITGB2', 'CAPG', 'CYTL1', 'SLC1A5']",0.9998923691042537,0,0,5
263,White fat cell differentiation WP4149,0.8906939454039948,0.5159077266100678,0.05971859251568846,"['EGR2', 'DDIT3']",0.9998923691042537,0,0,2
264,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8906939454039948,0.5159077266100678,0.05971859251568846,"['IFI27L2', 'HRAS']",0.9998923691042537,0,0,2
265,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8906939454039948,0.5159077266100678,0.05971859251568846,"['TRPC6', 'PAX2']",0.9998923691042537,0,0,2
266,Apoptosis WP254,0.891855116616698,0.55859375,0.06393194000952197,"['BAD', 'CYCS', 'BAX']",0.9998923691042537,0,0,3
267,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.891855116616698,0.55859375,0.06393194000952197,"['POMC', 'BAD', 'HRAS']",0.9998923691042537,0,0,3
268,Vitamin D Receptor Pathway WP2877,0.9011393618438975,0.6687640449438202,0.06961523314554116,"['LRRC25', 'COLEC11', 'GADD45A', 'ALOX5', 'S100A6', 'TNFAIP3', 'TNFRSF11B', 'CD14', 'S100A9']",0.9998923691042537,0,0,9
269,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.9043690535728033,0.4194042316258352,0.04215757255405617,['TLR1'],0.9998923691042537,0,0,1
270,Bladder cancer WP2828,0.9043690535728033,0.4194042316258352,0.04215757255405617,['HRAS'],0.9998923691042537,0,0,1
271,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9043690535728033,0.4194042316258352,0.04215757255405617,['HCK'],0.9998923691042537,0,0,1
272,Canonical and non-canonical Notch signaling WP3845,0.9043690535728033,0.4194042316258352,0.04215757255405617,['DLL3'],0.9998923691042537,0,0,1
273,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.9043690535728033,0.4194042316258352,0.04215757255405617,['TNFRSF11B'],0.9998923691042537,0,0,1
274,Fas ligand pathway and stress induction of heat shock proteins WP314,0.9043690535728033,0.4194042316258352,0.04215757255405617,['CYCS'],0.9998923691042537,0,0,1
275,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9043690535728033,0.4194042316258352,0.04215757255405617,['RRM2'],0.9998923691042537,0,0,1
276,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9043690535728033,0.4194042316258352,0.04215757255405617,['RAB13'],0.9998923691042537,0,0,1
277,RANKL/RANK signaling pathway WP2018,0.9043690535728033,0.4194042316258352,0.04215757255405617,['TNFRSF11B'],0.9998923691042537,0,0,1
278,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9043690535728033,0.4194042316258352,0.04215757255405617,['BAX'],0.9998923691042537,0,0,1
279,T-cell receptor (TCR) signaling pathway WP69,0.9112466592979224,0.47889791368052237,0.0445095678971536,"['ZAP70', 'HRAS']",0.9998923691042537,0,0,2
280,Pre-implantation embryo WP3527,0.9112466592979224,0.47889791368052237,0.0445095678971536,"['DDIT3', 'FOSB']",0.9998923691042537,0,0,2
281,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9112466592979224,0.47889791368052237,0.0445095678971536,"['CSF3R', 'F2RL2']",0.9998923691042537,0,0,2
282,22q11.2 copy number variation syndrome WP4657,0.9130200401827373,0.5581005586592179,0.050785727018129743,"['RANBP1', 'MRPL40', 'THAP7', 'LRRC74B']",0.9998923691042537,0,0,4
283,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9130200401827373,0.5581005586592179,0.050785727018129743,"['FZD9', 'WNT9A', 'HRAS', 'DLL3']",0.9998923691042537,0,0,4
284,Focal Adhesion WP306,0.9188979178839377,0.6160313901345291,0.052104084276913765,"['HCK', 'SHC3', 'BAD', 'ITGA8', 'RAC3', 'HRAS', 'MYL12B']",0.9998923691042537,0,0,7
285,Allograft Rejection WP2328,0.9249777526041505,0.5023995535714286,0.0391799271070495,"['HLA-DRB5', 'HLA-DRA', 'HLA-DOA']",0.9998923691042537,0,0,3
286,Gastrin signaling pathway WP4659,0.9249777526041505,0.5023995535714286,0.0391799271070495,"['CHGA', 'BAD', 'HRAS']",0.9998923691042537,0,0,3
287,ATM Signaling Pathway WP2516,0.9263508323430549,0.3726800296956199,0.028510859857984988,['GADD45A'],0.9998923691042537,0,0,1
288,Cardiac Progenitor Differentiation WP2406,0.9263508323430549,0.3726800296956199,0.028510859857984988,['MESP1'],0.9998923691042537,0,0,1
289,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9263508323430549,0.3726800296956199,0.028510859857984988,['ALOX5'],0.9998923691042537,0,0,1
290,Inflammatory Response Pathway WP453,0.9263508323430549,0.3726800296956199,0.028510859857984988,['ZAP70'],0.9998923691042537,0,0,1
291,Metabolic reprogramming in colon cancer WP4290,0.9263508323430549,0.3726800296956199,0.028510859857984988,['SLC1A5'],0.9998923691042537,0,0,1
292,Neural Crest Cell Migration during Development WP4564,0.9263508323430549,0.3726800296956199,0.028510859857984988,['F2RL2'],0.9998923691042537,0,0,1
293,Neural Crest Cell Migration in Cancer WP4565,0.9263508323430549,0.3726800296956199,0.028510859857984988,['F2RL2'],0.9998923691042537,0,0,1
294,Ovarian infertility WP34,0.9263508323430549,0.3726800296956199,0.028510859857984988,['GJA4'],0.9998923691042537,0,0,1
295,Exercise-induced Circadian Regulation WP410,0.9281324404676276,0.4468227424749164,0.03332441562473316,"['SUMO1', 'UCP3']",0.9998923691042537,0,0,2
296,Retinoblastoma gene in cancer WP2446,0.9281324404676276,0.4468227424749164,0.03332441562473316,"['RRM2', 'H2AFZ']",0.9998923691042537,0,0,2
297,Cell cycle WP179,0.9377900591598944,0.47831632653061223,0.03072186187191867,"['PTTG1', 'GADD45A', 'ANAPC11']",0.9998923691042537,0,0,3
298,Head and Neck Squamous Cell Carcinoma WP4674,0.9432840891006884,0.33530066815144766,0.019577461894778724,['HRAS'],0.9998923691042537,0,0,1
299,Imatinib and Chronic Myeloid Leukemia WP3640,0.9432840891006884,0.33530066815144766,0.019577461894778724,['GADD45A'],0.9998923691042537,0,0,1
300,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.9432840891006884,0.33530066815144766,0.019577461894778724,['EGR2'],0.9998923691042537,0,0,1
301,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9432840891006884,0.33530066815144766,0.019577461894778724,['ITGB2'],0.9998923691042537,0,0,1
302,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9432840891006884,0.33530066815144766,0.019577461894778724,['BAX'],0.9998923691042537,0,0,1
303,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9563273119697328,0.3047175541607613,0.013607177004697298,['ZAP70'],0.9998923691042537,0,0,1
304,Toll-like Receptor Signaling related to MyD88 WP3858,0.9563273119697328,0.3047175541607613,0.013607177004697298,['TLR1'],0.9998923691042537,0,0,1
305,IL-4 signaling pathway WP395,0.9563273119697328,0.3047175541607613,0.013607177004697298,['BAD'],0.9998923691042537,0,0,1
306,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9563273119697328,0.3047175541607613,0.013607177004697298,['AGT'],0.9998923691042537,0,0,1
307,Notch Signaling Pathway Netpath WP61,0.9563273119697328,0.3047175541607613,0.013607177004697298,['DLL3'],0.9998923691042537,0,0,1
308,Endoderm differentiation WP2853,0.9575600541325467,0.43643245341614906,0.018926696453809157,"['DUSP4', 'TCEAL2', 'NME1']",0.9998923691042537,0,0,3
309,AGE/RAGE pathway WP2324,0.9663733785005157,0.2792316258351893,0.00955111755574099,['CYCS'],0.9998923691042537,0,0,1
310,MECP2 and Associated Rett Syndrome WP3584,0.9663733785005157,0.2792316258351893,0.00955111755574099,['SST'],0.9998923691042537,0,0,1
311,Oncostatin M Signaling Pathway WP2374,0.9663733785005157,0.2792316258351893,0.00955111755574099,['HRAS'],0.9998923691042537,0,0,1
312,Osteoblast differentiation WP4787,0.9713190262154049,0.40125,0.011676499533211577,"['FZD9', 'WNT9A', 'DLL3']",0.9998923691042537,0,0,3
313,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9741104009338607,0.25766660955970533,0.006758758473112947,['TNFRSF11B'],0.9998923691042537,0,0,1
314,Thermogenesis WP4321,0.9741104009338607,0.25766660955970533,0.006758758473112947,['HRAS'],0.9998923691042537,0,0,1
315,Glioblastoma signaling pathways WP2261,0.9741104009338607,0.25766660955970533,0.006758758473112947,['HRAS'],0.9998923691042537,0,0,1
316,Spinal Cord Injury WP2431,0.9779934384447035,0.476563749800032,0.010604648168141924,"['GADD45A', 'APEX1', 'TNFSF13', 'MIF', 'PDYN', 'AIF1']",0.9998923691042537,0,0,6
317,Nuclear Receptors Meta-Pathway WP2882,0.9798655864418684,0.5763431151241535,0.011722746005998423,"['SERPINA1', 'SLC39A11', 'AIP', 'TNFAIP3', 'TXN', 'SLC2A5', 'SLC5A3', 'FTH1', 'SLCO2B1', 'ALOX5AP', 'BAX', 'CBR3', 'FTL']",0.9998923691042537,0,0,13
318,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9800686447801015,0.23918230989500477,0.004815377098186974,['ITGA8'],0.9998923691042537,0,0,1
319,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9800686447801015,0.23918230989500477,0.004815377098186974,['HRAS'],0.9998923691042537,0,0,1
320,TGF-beta Receptor Signaling WP560,0.9800686447801015,0.23918230989500477,0.004815377098186974,['HRAS'],0.9998923691042537,0,0,1
321,Prader-Willi and Angelman Syndrome WP3998,0.9800686447801015,0.23918230989500477,0.004815377098186974,['POMC'],0.9998923691042537,0,0,1
322,Peptide GPCRs WP24,0.9806407009710489,0.3185220576524924,0.006226833710847237,"['CCR1', 'HCRTR1']",0.9998923691042537,0,0,2
323,Hippo-Merlin Signaling Dysregulation WP4541,0.9843084192725994,0.3579001913265306,0.005660548287899897,"['ITGB2', 'ITGA8', 'HRAS']",0.9998923691042537,0,0,3
324,B Cell Receptor Signaling Pathway WP23,0.9845361610208079,0.30394243437721696,0.004736836835712669,"['PIK3AP1', 'HRAS']",0.9998923691042537,0,0,2
325,Toll-like Receptor Signaling Pathway WP75,0.9845361610208079,0.30394243437721696,0.004736836835712669,"['TLR1', 'CD14']",0.9998923691042537,0,0,2
326,Glucocorticoid Receptor Pathway WP2880,0.9845361610208079,0.30394243437721696,0.004736836835712669,"['ALOX5AP', 'TNFAIP3']",0.9998923691042537,0,0,2
327,Vitamin B12 metabolism WP1533,0.9846567063878083,0.22316258351893095,0.0034505889602311967,['F2'],0.9998923691042537,0,0,1
328,Wnt signaling pathway and pluripotency WP399,0.9846567063878083,0.22316258351893095,0.0034505889602311967,['FZD9'],0.9998923691042537,0,0,1
329,G1 to S cell cycle control WP45,0.9846567063878083,0.22316258351893095,0.0034505889602311967,['GADD45A'],0.9998923691042537,0,0,1
330,Ectoderm Differentiation WP2858,0.9876651091274318,0.29063060443022637,0.003607189957435935,"['TNFRSF11B', 'LY6E']",0.9998923691042537,0,0,2
331,Lung fibrosis WP3624,0.988189405735768,0.20914532293986637,0.002484833286385148,['SERPINA1'],0.9998923691042537,0,0,1
332,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9890388421367001,0.4906981027813594,0.00540831451060588,"['FGF17', 'PFKFB1', 'GNG10', 'GNG3', 'CSF3R', 'BAD', 'ITGB2', 'ITGA8', 'HRAS']",0.9998923691042537,0,0,9
333,Complement and Coagulation Cascades WP558,0.9901738148524671,0.27842809364548493,0.0027494163671834843,"['SERPINA1', 'F2']",0.9998923691042537,0,0,2
334,Regulation of toll-like receptor signaling pathway WP1449,0.9931458938438174,0.312744140625,0.0021509614483986605,"['TLR1', 'TNFAIP3', 'CD14']",0.9998923691042537,0,0,3
335,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9958558428804215,0.1670935412026726,0.0006939007003273492,['FZD9'],0.9998923691042537,0,0,1
336,Myometrial relaxation and contraction pathways WP289,0.9962854761101482,0.3248398964436572,0.0012088721404974383,"['GNG3', 'IGFBP2', 'CRH', 'IGFBP6']",0.9998923691042537,0,0,4
337,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9968108067509738,0.1590836780146357,0.0005081593325044709,['FZD9'],0.9998923691042537,0,0,1
338,Neural Crest Differentiation WP2064,0.9968108067509738,0.1590836780146357,0.0005081593325044709,['DLL3'],0.9998923691042537,0,0,1
339,PI3K-Akt signaling pathway WP4172,0.9981740604683602,0.39586578890061475,0.0007234877167848307,"['FGF17', 'GNG10', 'GNG3', 'CSF3R', 'BAD', 'ITGA8', 'PIK3AP1', 'HRAS']",0.9998923691042537,0,0,8
340,"GPCRs, Class A Rhodopsin-like WP455",0.9984641684025323,0.38991219383376247,0.000599299797202153,"['CCR1', 'GPR65', 'OR7A5', 'APLNR', 'GPR37L1', 'OR7C1', 'F2RL2', 'HCRTR1']",0.9998923691042537,0,0,8
341,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.998772784009009,0.24952566964285713,0.0003064099460207917,"['SST', 'AVP', 'ALDOA']",0.9998923691042537,0,0,3
342,Wnt signaling WP428,0.9988814262772766,0.1334521158129176,0.00014935958042314876,['FZD9'],0.9998923691042537,0,0,1
343,"GPCRs, Other WP117",0.999139059183472,0.12827651190680145,0.00011048605270609006,['ADGRE2'],0.9998923691042537,0,0,1
344,Mesodermal commitment pathway WP2857,0.9996069785772598,0.1148913293909838,4.5163629456180214e-05,['RPL38'],0.9998923691042537,0,0,1
345,Calcium Regulation in the Cardiac Cell WP536,0.9997702872455162,0.166164994425864,3.817460333287783e-05,"['GNG3', 'GJA4']",0.9998923691042537,0,0,2
346,Metapathway biotransformation Phase I and II WP702,0.9998923691042537,0.09783178304729465,1.0530289144228745e-05,['GPX4'],0.9998923691042537,0,0,1
